This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2000 Apr;18(8):1801-2.

doi: 10.1200/JCO.2000.18.8.1801.

Standards of reporting quality of life in clinical trials

R Stephens, P Hopwood

PMID: 10764442
DOI: 10.1200/JCO.2000.18.8.1801

Comment

Standards of reporting quality of life in clinical trials

R Stephens et al. J Clin Oncol. 2000 Apr.

. 2000 Apr;18(8):1801-2.

doi: 10.1200/JCO.2000.18.8.1801.

Authors

R Stephens, P Hopwood

PMID: 10764442
DOI: 10.1200/JCO.2000.18.8.1801

No abstract available

PubMed Disclaimer

Comment on

Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life.
Cullen MH, Billingham LJ, Woodroffe CM, Chetiyawardana AD, Gower NH, Joshi R, Ferry DR, Rudd RM, Spiro SG, Cook JE, Trask C, Bessell E, Connolly CK, Tobias J, Souhami RL. Cullen MH, et al. J Clin Oncol. 1999 Oct;17(10):3188-94. doi: 10.1200/JCO.1999.17.10.3188. J Clin Oncol. 1999. PMID: 10506617 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information